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Abstract
P21-activated kinase 1 (PAK1), a serine/threonine protein kinase, modulates many cellular processes by phosphorylating its
downstream substrates. In addition to its role in the cytoplasm, PAK1 also affects gene transcription due to its nuclear
localization and association with chromatin. It is now recognized that PAK1 kinase activity and its nuclear translocation are
rapidly stimulated by ionizing radiation (IR), and that PAK1 activation is a component of the DNA damage response. Owing
to the role of PAK1 in the cell survival, its association with the chromatin, and now, stimulation by ionizing radiation, we
hypothesize that PAK1 may be contributing to modulation of genes with roles in cellular processes that might be important
in the DNA damage response. The purpose of this study was to identify new PAK1 targets in response to ionizing radiation
with putative role in the DNA damage response. We examined the effect of IR on the gene expression patterns in the
murine embryonic fibroblasts with or without Pak1 using microarray technology. Differentially expressed transcripts were
identified using Gene Spring GX 10.0.2. Pathway, network, functional analyses and gene family classification were carried
out using Kyoto Encyclopedia of Genes and Genomes (KEGG), Ingenuity Pathway, Gene Ontology and PANTHER
respectively. Selective targets of PAK1 were validated by RT-qPCR. For the first time, we provide a genome-wide analysis of
PAK1 and identify its targets with potential roles in the DNA damage response. Gene Ontology analysis identified genes in
the IR-stimulated cells that were involved in cell cycle arrest and cell death. Pathway analysis revealed p53 pathway being
most influenced by IR responsive, PAK1 targets. Gene family of transcription factors was over represented and gene
networks involved in DNA replication, repair and cellular signaling were identified. In brief, this study identifies novel PAK1
dependent IR responsive genes which reveal new aspects of PAK1 biology.
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adhesion and cytokinesis by phosphorylating several downstream
substrates [3,7–9]. PAK1 also promotes cell survival through
direct phosphorylation-induced BAD inactivation [10] and indirectly through several substrates, including NF-kB-inducing
kinases [11] dynein light-chain 1 [12] and fork-head transcription
factor in response to various stimuli. Furthermore, increased
PAK1 expression and activity have been documented in a variety
of human cancers, including breast, colon, ovarian, bladder, and
brain cancers [1,3].
In addition to its well-characterized kinase activity, it is
increasingly recognized that PAK1 also affects nuclear events,
presumably by modulating coactivator/corepressor mediated gene
regulation [13]. Earlier studies have demonstrated that PAK1
could be localized in the nuclear compartment and nuclear PAK1
associates with chromatin, suggesting that it might be involved in
gene transcription [13]. In support of this notion, nuclear PAK1
has been shown to interact with the phosphofructokinase-muscle
isoform (PFK-M) and nuclear factor of activated T-cell (NFAT1)
genes and is involved in regulating their transcription [13].
Furthermore, it has been shown that PAK1 phosphorylates histone

Introduction
The mammalian PAK family contains six serine/threonine
kinases divided into two subgroups, group I (PAK 1–3) and group
II (PAK 4–6) on the basis of structural and functional similarities
[1–3]. Although members of this family share significant homology
in the kinase domain , the biological functions of each member are
distinct and they are dictated by the variable N-terminal
regulatory domain [1,2].
Among them, PAK1 is the founding and best-characterized
member of this family, originally discovered in rat brain as a
serine/threonine protein kinase was found to be activated by the
P21ras-related proteins Cdc42 and Rac1 [4]. To date, it is clear
that a variety of extracellular signals, such as growth factors [5],
insulin [6], and lipids [3], can activate PAK1 by promoting its
auto-phosphorylation on several sites [1–3]. Once activated,
PAK1 phosphorylates its downstream substrates, that are responsible for various biological effects of PAK1 kinase in cancer cells
[1,3]. In this context, studies have shown that PAK1 regulates
actin cytoskeleton that is crucial for cell morphogenesis, motility,
PLOS ONE | www.plosone.org
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H3 on serine 10, a site important in chromosome condensation
and transcriptional activation [14]. PAK1 also regulates cyclin D1
transcription by means of a nuclear factor-kappa B (NF-kB)dependent pathway [15]. In this case, increased expression of
PAK1 in breast cancer cells stimulates cyclin D1 promoter activity,
increases cyclin D1 mRNA levels, and promotes nuclear
accumulation of cyclin D1 [15]. Collectively, these findings
suggest that PAK1 could have a role in transcriptional regulation
in addition to its putative signaling activity.
More recently, PAK1 signaling has emerged as a component of
the DNA damage response as PAK1 status influences the cellular
sensitivity to ionizing radiation [16]. However the role of genomewide PAK1 targets in cells under genotoxic stress such as ionizing
radiation remains unknown. Therefore this study was undertaken
to identify putative potential PAK1 targets in response to ionizing
radiation.

The overall aim of the study was to identify the genes that are
regulated by Pak1 in response to DNA damaging agents such as
ionizing radiation (IR). To reveal the role of Pak1 on the gene
expression, we have subjected the wild-type (WT) and PAK1
knock-out (KO) murine embryonic fibroblasts (MEFs) to microarray analysis using Affymetrix Mouse Exon 1.0 ST chips.
Microarray data normalization and analysis was performed using
Gene Spring GX 10.0.2 (Agilent Technologies) to obtain lists of
probe sets that were significantly affected by knockout of Pak1. To
identify the genes regulated by PAK1 in response to IR, the WT
and PAK1 KO MEFs were subjected to ionizing radiation dose
rate of 3.04 Gy/min at room temperature. We deduced the IR
responsive gene list by various cross comparisons between genes
lists obtained after analyzing wild-type (WT) and wild-type treated
with IR (WT-IR) samples and WT-IR and knock-out treated by
IR (KO-IR) samples. This strategy allowed us to identify the genes
that were regulated by Pak1 and bonafide Pak1 targets during
DNA damage. This potential list of genes was subjected to
function, pathway and network analysis by using the Gene
Ontology (GO) from Gene Spring, Database for Annotation,
Visualization and Integrated Discovery (DAVID) tool and
Ingenuity Pathways Analysis (IPA), respectively. Protein Analysis
Through Evolutionary Relationships (PANTHER) was used to
identify overrepresented and underrepresented gene families in the
respective data sets. Reverse Transcription-quantitative PCR (RTqPCR) was performed to validate the microarray gene regulation
of the selected candidate genes in the MEFs. These analyses using
both non-IR and IR treated cells helped us identify a set of novel
Pak1 targets that are specifically regulated during the DNA
damage response. The overall experimental workflow is shown in
Figure 1.

Table 1 and Table 2, respectively. Highly up-regulated (up to 44fold change) in the Pak1-KO MEFs are Pdlim1 gene PDZ - LIM
domain 1 and Sgce gene (sarcoglycan-epsilon) which encodes the
epsilon member of the sarcoglycan family . Both PDLIM1 and
SGCE are known to play role in human cancers and cytoskeleton
signaling [17] [18] [19] [20]. SGCE is a member of transmembrane proteins, which acts as a link between actin cytoskeleton and
the extra cellular matrix and is also implicated in neuronal
disorder such as myoclonus-dystonia syndrome . PDLIM1, also
known as CLP36, a potential tumor antigen in pancreatic
carcinoma, is required for actin stress-fiber formation and focal
adhesion in choriocarcinoma which corroborates with functions of
PAKs of phosphorylating LIM domain kinase that are regulators
of cytoskeleton. [21] Other genes, including receptor-interacting
serine-threonine kinase 3 (Ripk3), four and a half LIM domains 1
(Fhl1), and 1-acylglycerol-3-phosphate O-acyltransferase 2 (Agpat2), were also significantly up-regulated in the Pak1-KO cells
compared to its wild-type counterparts (Table 1). Interestingly,
most of the identified targets show coherence with the putative
PAK1 function in cytoskeleton dynamics [1,3,22].
As shown in Table 2, the ribosomal protein S6 kinase/RSK4
was observed to be 17-fold down-regulated in the Pak1-KO cells
compared to the wild-type controls. RSK4, an intracellular serine/
threonine kinase, belongs to p90 ribosomal S6 kinase (RSK) family
of related kinases that phosphorylate numerous cytosolic and
nuclear targets and act as downstream effectors of the extracellular
signal-regulated kinase/mitogen-activated protein kinase signaling
cascade [23]. RSK4 is commonly deleted in patients with complex
X-linked mental retardation, suggesting that RSK4 plays a role in
normal neuronal development [24]. In addition, RSK4 has been
reported to be deleted or down-regulated in many human cancers
such as colon [16,25] and breast cancers [26] [27]. the RSK family
of proteins, RSK1 and RSK2 shown to phosphorylate filamin A
cytoskeletal protein that crosslinks actin filaments and is essential
for mammalian cell motility [28]. Other most significantly downregulated genes due to Pak1 knockout include insulin-like SRYbox containing gene 2 (Sox2), a pluripotent gene and an important
transcription factor found overexpressed in various cancers such as
colon, lung and breast. It is known to contribute to tumor
initiation and propagation in mammary cells as well as donwregulation of this gene suppresses growth and metastasis in lung
cancer [29] [30]. It is interesting to note that there are several
known functional avenues including neuronal development,
cytoskeletal, cell motility signaling, and oncogenic signaling are
influenced by Pak1. Our data indicates possible unexplored
interplay between such substrates and Pak1 which may be through
genomic regulation. Other genes include hyaluronan synthase 2
(Has2), eukaryotic translation initiation factor 2, subunit 3,
structural gene Y-linked (Eif2s3y) and insulin-like growth factor
binding protein 3(Igfbp) (Table 2). Collectively, these analyses
provide a genome-wide view of a set of new Pak1 targets with roles
in various biological processes.

Identification of differentially expressed genes in wildtype and Pak1-knockout MEFs

Genes regulated by Pak1 in response to DNA Damage
stimuli

Gene Spring GX 10.0.2 was used to analyze the raw data
obtained from microarray hybridization. The initial comparison
between the wild type and the Pak1 knock out cell files was
performed using unpaired t-test with a p-value less than 0.05.
Benjamini Hochberg false discovery rate (FDR) was applied for
the multiple corrections. We have identified 731 Pak1 target genes
(table S1) with a fold change $62.0 and with the p-value,0.05.
The lists of the top 20 genes that were up-or down-regulated in the
Pak1-KO MEFs compared to wild-type MEFs are shown in

To achieve our aim of identifying the Pak1 regulated genes
under ionizing radiation, we performed statistical tests between the
wild type cells treated with IR (WT-IR) and Pak1-KO cells treated
with IR (KO-IR) that used a p-value less than 0.05, fold change
$62.0 and the Benjamini Hochberg false discovery rate (FDR)
correction parameter to eliminate false positives. This comparison
yielded a list of genes that might be differentially regulated due to
three main reasons: a) mere knockout of the gene b) effect of IR
alone or c) both knockout and IR. The genes that are differentially

Results and Discussion
Strategy to identify potential targets of Pak1 in IR and
non-IR scenarios

PLOS ONE | www.plosone.org
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Figure 1. Schematic representing identification of differentially expressed genes by microarray analysis. (A) Flowchart representing
the global gene expression profiling in the WT and Pak1 KO and WT and Pak1 KO IR treated MEFs. RNA was isolated from triplicates of each sample
and microarray analysis was performed using the Affymetrix Mouse exon 1.0 chip arrays. The gene expression data was obtained for different samples
that were cross compared to identify differentially expressed genes regulated by Pak1 in IR and non-IR scenarios. Functional and pathway analysis
was performed to analyze biological significance of differentially regulated genes. Selected genes were verified by qPCR in MEFs.
doi:10.1371/journal.pone.0066585.g001

genes were not taken into consideration and assumption has been
made that such genes, if any, might be very few in number.
Therefore, by filtering, we obtained the final list of target genes
that might be involved in DNA damage response mechanisms as
well as affected by absence of Pak1 and hence were ‘‘bonafide’’. A
total of 199 genes passed these selection criteria and achieved
statistical significance (p-value,0.05 and fold change $2.0) (table
S2). Top 20 up-regulated and down- regulated Pak1 influenced
genes after ionization radiation treatment are shown in Table 3
and Table 4 respectively. Interestingly, the highly up regulated
target genes cyclin dependent kinase inhibitor 1 A (Cdkn1a),
transformation related protein 53 inducible nuclear protein 1
(Trp53inp1), B cell translocation gene 2 (Btg2), SET domain
containing (lysine methyltransferase) 8, appeared to be clusters of

regulated due to both knock out and IR are likely to be involved in
DNA damage response in a Pak1-dependent manner. To obtain
this set of genes, we eliminated the ‘only IR’ effected genes by
comparing the WT and WT-IR samples from the list of WT-IR vs
KO-IR. Next we eliminated all the differentially expressed genes
that were present due to ‘only KO’ of Pak1. At this stage of
filtering, we compared the fold changes of the genes between WT
vs KO and the WT-IR vs KO-IR. If fold change was same in both
cases we eliminated those genes by concluding that the gene is
affected by ‘Only KO’ but not IR. One can argue that the up or
down regulation of the gene caused due to the KO of Pak1 in
MEFs might be exactly compensated with the effect IR so that in
the end there is a null fold change difference. Addressing this point
is almost impossible using microarray technology, hence those
PLOS ONE | www.plosone.org
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Table 1. List of the top 20 up-regulated genes in the Pak1 KO MEFs compared to wild-type MEFs.

Refseq

Fold
change

Regulation

Gene symbol Gene description

NM_016861

44.63

up

Pdlim1

NM_001130188

41.29

up

Sgce

sarcoglycan, epsilon

NM_001164108

28.42

up

Ripk3

receptor-interacting serine-threonine kinase 3

NM_133187

24.49

up

Fam198b

family with sequence similarity 198, member B

NM_001077361

22.38

up

Fhl1

four and a half LIM domains 1

NM_026212

18.84

up

Agpat2

1-acylglycerol-3-phosphate O-acyltransferase 2

NM_011671

18.24

up

Ucp2

uncoupling protein 2 (mitochondrial, proton carrier)

NM_008056

16.92

up

Fzd6

frizzled homolog 6 (Drosophila)

NM_001159518

15.73

up

Igfbp7

insulin-like growth factor binding protein 7

NM_010345

15.22

up

Grb10

growth factor receptor bound protein 10

NM_013657

13.85

up

Sema3c

sema domain, immunoglobulin domain (Ig)

NM_010426

13.55

up

Foxf1a

forkhead box F1a

NM_013560

12.16

up

Hspb1

heat shock protein 1

NM_009152

12.00

up

Sema3a

sema domain, immunoglobulin domain (Ig)

NM_181315

11.69

up

Car5b

carbonic anhydrase 5b, mitochondrial

NM_173006

11.08

up

Pon3

paraoxonase 3

NM_133200

10.97

up

P2ry14

purinergic receptor P2Y, G-protein coupled, 14

NM_008397

10.17

up

Itga6

integrin alpha 6

NM_178395

9.87

up

Zdhhc2

zinc finger, DHHC domain containing 2

NM_007494

8.98

up

Ass1

argininosuccinate synthetase 1

PDZ and LIM domain 1 (elfin)

doi:10.1371/journal.pone.0066585.t001

Table 2. List of the top 20 down -regulated genes in the Pak1 KO MEFs compared to wild-type MEFs.

Refseq

Fold change

Regulation

Gene symbol

Gene description

NM_025949

17.81

down

Rps6ka6

ribosomal protein S6 kinase polypeptide 6

NM_011443

12.38

down

Sox2

SRY-box containing gene 2

NM_008216

11.23

down

Has2

hyaluronan synthase 2

NM_008343

10.79

down

Igfbp3

insulin-like growth factor binding protein 3

NM_012011

9.78

down

Eif2s3y

eukaryotic translation initiation factor 2

NM_134096

9.39

down

Fam19a5

family with sequence similarity 19

NM_009369

9.25

down

Tgfbi

transforming growth factor, beta induced

NM_012008

8.91

down

Ddx3y

DEAD box polypeptide 3,

NM_007539

8.27

down

Bdkrb1

bradykinin receptor, beta 1

NM_026058

7.74

down

Lass4

LAG1 homolog, ceramide synthase 4

NM_009378

7.36

down

Thbd

thrombomodulin

NM_011581

7.19

down

Thbs2

thrombospondin 2

NM_010357

7.18

down

Gsta4

glutathione S-transferase, alpha 4

NM_009484

7.17

down

Uty

ubiquitously transcribed tetratricopeptide

NM_015744

6.96

down

Enpp2

ectonucleotide pyrophosphatase

NM_010308

6.49

down

Gnao1

guanine nucleotide binding protein, alpha O

NM_080288

6.27

down

Elmo1

engulfment and cell motility 1

NM_008973

6.00

down

Ptn

pleiotrophin

NM_175730

5.45

down

Hoxc5

homeobox C5

NM_001037937

5.30

down

Depdc6

DEP domain containing 6

doi:10.1371/journal.pone.0066585.t002
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the hierarchical clustering analysis with the genes that were
differentially regulated between the WT vs. Pak1-KO and that
were Pak1 regulated, IR responsive genes. The normalized log2
ratio values of the differentially regulated genes in each
comparison were used to obtain the heat maps (Figure 2B). The
gene leaf nodes were optimized in the heat maps representing the
differential regulation of the genes within the samples. Coloring
scale of the heat map shows red as the up regulated, green as down
regulated and black as insignificant differential expression. We
found that 56% of the differentially regulated genes were upregulated in WT vs. Pak1-KO whereas 44% were down regulated.
Following the IR treatment 68% were found to be up regulated
and 32% down regulated in the KO samples as compared to the
wild type.

genes involved in cell cycle arrest. The family of genes such as
Ectodysplasin A2 receptor, adrenergic receptor, beta 2 pleckstrin
homology-like domain, family A, member 3, p53-induced protein
(sestrin), G two S phase expressed protein 1 and DNA-damageinducible transcript 4 have been reported to be involved in P53
signalling in DNA damage. For instance, ectodysplasin A2 receptor,
a signaling molecule belonging to the tumor necrosis factor family,
required for normal development of several ectodermally derived
organs in humans and mice has been shown to be a direct P53 target
in colorectal cancer [31]. Another target gene, PHLDA3, an
established p53 responsive gene that encodes a PH domain-only
protein is shown to influence p53-dependent apoptosis through Akt
and subsequently established to be a central player in tumor
suppression. [32]. Finally, DDIT4 (DNA damage-inducible transcript 4), a P53 transcriptional target stress-response gene that
negatively regulates the mTOR pathway is also upregualted by
PAK1 and IR treatment. The mTOR (mammalian target of
rapamycin) protein kinase is the central node in nutrient and growth
factor signaling, and activation of p53 inhibits mTOR activity,
tumor suppression processes such as autophagy and regulates its
downstream targets. [33]. In summary, PAK1 appears to be a
critical player that is necessary for the genomic regulation of several
genes that are involved in p53 mediated DNA damage signaling. Of
note, the genomic regulatory functions of PAK1 are at an early stage
of understanding and our findings represent a wealthy resource to
gain a deeper insight into PAK1 biology.

Gene ontology (GO) analysis of Pak1 knockout with and
without IR treatment
To understand the functions of these differentially expressed
probe sets, we performed GO analysis using Gene Spring GX
10.0.2. on all the sets of genes that were regulated by Pak1 and
Pak1-regulated DNA damage responsive genes with a p-value
cutoff set to 0.1. The results showed that 32.02% of these genes
matched the GO term ‘‘Biological Processes’’, 32.67% had
‘‘Molecular Functions’’, and 35.31% matched ‘‘Cellular Component’’ (Figure 3A). When we analyzed the PAK1 dependent IR
regulated genes, a contrasting 16.11% were involved in ‘‘Molecular Functions’’, 45% in ‘‘Biological Processes’’ and 38.89%
matched ‘‘Cellular Component’’ (Figure 3B). To analyze the
functions we further expanded the Gene Ontology terms to study
biological processes and molecular functions and studied significant processes based their p-values. PAK1 regulated genes were

Hierarchical clustering analysis of Pak1 on gene
expression with and without IR treatment
PAK1 protein level in the WT and KO MEFs were checked
using western blotting and is shown in Figure 2A. We performed

Table 3. List of the top 20 IR responsive genes upregulated by genes in the IR treated Pak1 KO MEFs compared to its IR treated
wild-type MEFs.

Refseq

Fold
change

Regulation

Gene symbol Gene description

NM_007669

26.87

up

Cdkn1a

cyclin-dependent kinase inhibitor 1A

NM_021897

23.48

up

Trp53inp1

transformation related protein 53 inducible nuclear protein 1

NM_007570

16.05

up

Btg2

B-cell translocation gene 2, anti-proliferative

NM_009855

15.69

up

Setd8

SET domain containing 8

NM_007494

14.41

up

Ass1

argininosuccinate synthetase 1

NM_030143

14.33

up

Ddit4l

DNA-damage-inducible transcript 4-like

NM_021274

11.79

up

Cxcl10

chemokine (C-X-C motif) ligand 10

NM_021451

9.43

up

Pmaip1

phorbol-12-myristate-13-acetate-induced protein 1

NM_010786

6.05

up

Mdm2

transformed mouse 3T3 cell double minute 2

NM_013473

5.97

up

Anxa8

annexin A8

NM_020275

5.68

up

Tnfrsf10b

tumor necrosis factor receptor superfamily, member 10b

NM_001161432

5.35

up

Eda2r

ectodysplasin A2 receptor

NM_008651

4.48

up

Mybl1

myeloblastosis oncogene-like 1

NM_007420

4.29

up

Adrb2

adrenergic receptor, beta 2

NM_013750

3.88

up

Phlda3

pleckstrin homology-like domain, family A, member 3

NM_144907

3.81

up

Sesn2

sestrin 2

NM_008331

3.72

up

Ifit1

interferon-induced protein with tetratricopeptide repeats 1

NM_024223

3.59

up

Crip2

cysteine rich protein 2

NM_013882

3.52

up

Gtse1

G two S phase expressed protein 1

NM_013642

3.50

up

Dusp1

dual specificity phosphatase 1

doi:10.1371/journal.pone.0066585.t003
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Table 4. List of the top 20 IR responsive genes down regulated by genes in the IR treated Pak1 KO MEFs compared to its IR treated
wild-type MEFs.

Refseq

Fold change

Regulation

Gene symbol

Gene description

NM_007539

6.32

down

Bdkrb1

bradykinin receptor, beta 1

NM_028133

3.35

down

Egln3

EGL nine homolog 3 (C. elegans)

NM_021532

3.22

down

Dact1

dapper homolog 1

NM_008970

2.50

down

Pthlh

parathyroid hormone-like peptide

NM_138747

2.42

down

Nop2

NOP2 nucleolar protein homolog (yeast)

NM_010499

2.39

down

Ier2

immediate early response 2

NM_009227

2.38

down

Snrpe

small nuclear ribonucleoprotein E

NM_001011721

2.35

down

Olfr102

olfactory receptor 102

NM_001161845

2.30

down

Sgk1

serum/glucocorticoid regulated kinase 1

NM_008492

2.30

down

Ldhb

lactate dehydrogenase B

NM_019444

2.29

down

Ramp2

receptor (calcitonin) activity modifying protein 2

NM_021878

2.25

down

Jarid2

jumonji, AT rich interactive domain 2

NM_173011

2.24

down

Idh2

isocitrate dehydrogenase 2

NM_007514

2.22

down

Slc7a2

solute carrier family 7, member 2

NM_001012477

2.19

down

Cxcl12

chemokine (C-X-C motif) ligand 12

NM_010898

2.18

down

Nf2

neurofibromatosis 2

NM_178891

2.18

down

Prmt6

protein arginine N-methyltransferase 6

NM_009930

2.17

down

Col3a1

collagen, type III, alpha 1

NM_025392

2.158529

down

Bccip

BRCA2 and CDKN1A interacting protein

NM_029936

2.1434464

down

Ddx10

DEAD (Asp-Glu-Ala-Asp) box polypeptide 10

doi:10.1371/journal.pone.0066585.t004

processes. The details of overall GO terms involved are shown in
table S3 and S4 for the non-IR and IR scenarios.

involved in molecular functions such as ‘‘catalytic activity’’
‘‘binding’’ and ‘‘transcription factor activity’’. Catalytic activity
mainly comprised of hydrolase and transferase activity representing large number of enzymes that were affected by loss of PAK1.
Transcription factor activity constituted sequence specific DNA
binding genes. This analysis revealed a specific set of genes that
were regulated by PAK1 and were crucial for transcription
machinery (Figure 4A). Contrasting to this scenario PAK1
dependent IR responsive genes were significantly involved in
‘‘binding’’ which is a broad category that includes all different
kinds of binding such as protein binding, nucleic acid binding and
receptor binding (Figure 4B). To understand what processes were
being affected by the loss of PAK1 kinase we expanded the GO
term ‘‘Biological Process’’ and found that PAK 1 regulated genes
and PAK1 regulated IR responsive genes regulate distinct
processes. PAK1 dependent genes were involved in processes
such as ‘‘biological adhesion’’, ‘‘metabolic processes’’ such as
nucleic acid metabolism and phosphorylation, ‘‘developmental
processes’’ such as blood vessel development, skeletal system
development, embryonic and nervous development, and many
‘‘regulatory processes’’ like regulation of transcription, cell
proliferation, cell motility and migration (Figure 5A). The IR set
of genes represented very specific processes characteristic of IR
scenario such as ‘‘cellular process’’ involving cell cycle arrest, cell
death ‘‘death’’ mainly apoptosis, ‘‘response to stimulus’’ like stress
and radiation ‘‘biological regulation’’ like regulation of cell death,
cell growth, cell cycle and cellular proliferation. (Figure 5B). The
Gene Ontology analysis provided an overview of various functions
and biological processes in which these genes were involved. Pak1
regulated IR responsive genes were mainly involved in various
DNA damage responsive events like cell cycle arrest and apoptosis
whereas Pak1 1 KO genes displayed functions in developmental
PLOS ONE | www.plosone.org

Comparative analysis of pathways and networks in nonIR and IR stimulated scenarios
To understand if the gene sets were involved in biological
pathways we used DAVID 6.7 tool to analyze various KEGG
pathways, enriched with the sets of upregulated and down
regulated genes. Most of the genes that had altered expression
due to loss of Pak1 belong to pathways in cancer cytokine-cytokine
receptor interaction, purine metabolism, focal adhesion and
endocytosis. As defined by KEGG database ‘Cytokine-cytokine
receptor interaction pathway constitutes of cytokines which are
crucial intercellular regulators during inflammatory host defenses,
cell growth, differentiation, cell death, angiogenesis, and homeostasis’. PAK1 is known to control MAP kinases like JNK and p38
signaling kinases which respond to stress stimuli and regulate
cellular processes. [34]. Also the modulation of NF-kB signaling by
Pak1 has been well documented. [11]. Cytoskeleton dynamics and
formation of stress fibers that are mediated by PAK1 play an
important role in cell matrix interactions during an inflammatory
event. All these findings support a potential involvement of Pak1 in
cytokine-cytokine receptor interaction which has not been
explored. Also, Pak1-KO influenced many new targets such as
chemokines, platelet derived growth factors, transforming growth
factors and tumor necrosis factors that are components of this
pathway and haven’t been studied with respect to Pak1. Pathways
like cancer and focal adhesion pathways represent known
functions of Pak1. In contrast, Pak1 regulated IR responsive genes
were involved in pathways such as p53 signaling, cancer,
proponoate metabolism and cell cycle. Although the p53
dependent functions of Pak1 have been investigated before [35]
6
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Figure 2. Hierarchical clustering of differentially regulated genes. (A) Western blot analysis of Pak1 in the WT and Pak1 KO MEFs. The same
membrane was probed with anti-vinculin as loading control. (B) Heat map shows the hierarchical clustering of the differentially expression genes
generated by MultiExperiment Viewer version 4.4. The log2 expression values of the genes are represented on the color scale from green indicating
down-regulation to red indicating an up-regulation, interpolated over black region representing no significant change in expression of the genes
when Pak1 is knocked out. The differential expression analysis was performed with P,0.05 using Benjamini Hochberg method and fold change $2.0.
doi:10.1371/journal.pone.0066585.g002

here Pak1 appears to regulate several target genes that are
involved in p53 signaling, which have long been established to be
central to DNA damage.. The P53 protein plays a pivotal role in
DNA damage response and tumor suppression and depending on
the stress signal various signaling cascades are activated. Important
genes such as Mdm2(6 fold upregulated in knock out samples)
invloved in cell cycle and p53 feedback loop, Apaf1(2.6 fold
upregulated) and Noxa which are involved in apoptosis, Sestrins(3.8
fold upregulated) responsible for DNA damage repair were shown
be altered due to loss of Pak1. The top 5 pathways for the non-IR
and IR set are shown in Figure 6a and 6b respectively and the
remaining significant pathways are shown in Tables 5 and 6. . The
p-value used to compute the KEGG pathways was equal to 0.1,
Bonferroni and Benjaminicorrections were applied for the
analysis. (tables S5 and S6).
These findings were reconfirmed using Ingenuity Pathway
Analysis (IPA) (release Winter 2012) to generate a network which
aggregates the genes from our data set based on known
relationships, functions and diseases. The top network of Pak1
regulated genes involved ‘‘Cellular Movement, Cancer, Tissue
Development’’, which is in coherence with GO terms such as
‘‘regulation of cell motility’’. Similarly, tissue development
incorporates GO term ‘‘developmental system’’. Thus, by
applying two different algorithms, our analysis highlighted related
pathways and functions. The network analysis brings out the
major theme in Pak1 regulated genes. Similarly, the top network
in Pak1 dependent IR responsive genes was the ‘‘Cellular Growth
and Proliferation, DNA Replication, Recombination, and Repair,
Cell Signaling’’ which establishes the main theme found in these
sets of genes which is in agreement with the GO term functional
analysis and KEGG pathways. The top 5 networks by IPA in both
non-IR and IR scenarios are provided in table S7.

Gene family classification
Having established the differentiated pathways and functions of
Pak1 in IR and non-IR scenarios, we then explored the
possibilities of over or under represented gene families in these
sets of lists using PANTHER tool (version 7.0). PANTHER
protein class tool compares the set of altered genes to the reference
genome, in this case Mus Musculus, and computes if our data set is
enriched with categories of gene or protein families(table S8). We
chose the top gene families (Figure 7) based on their p-values from
both the IR and non-IR sets and observed that three classes of
gene families which were transcription factors, transferases and
transporters were over represented for both the sets, whereas gene
families like the histones and extracellular matrix genes were
specific to only Pak1 regulated genes and were underrepresented
in IR scenario. Tumor necrosis receptor family and transcription
factors were over represented in IR scenarios. These gene families

Figure 4. Gene Ontology Tree for Molecular Functions. The
Gene Ontology analysis follows a hierarchical way of assigning GO
terms to genes. A GO tree is an expansion to lower level terms that
allows us to know specific functional categories. Figure (A) represents
lower level classifications of molecular functions by PAK1 regulated
genes. (B) Shows the same for PAK1 regulated DNA damage responsive
genes. All the categories follow statistical significant value of p,0.01.
Pak1 regulated genes are involved in molecular functions such as
‘‘Transcription factor activity’’, ‘‘catalytic activity’’ and ‘‘binding’’ where
as Pak1 regulated IR responsive genes were only involved in ‘‘binding’’.
All the categories are statistically significant with P- value,0.01.
doi:10.1371/journal.pone.0066585.g004

Figure 3. Gene Ontology analysis. The figure represents the pie
chart view of the GO analysis performed by Genespring GX 10.0.2. The
percentages represent statistically significant (p,0.1) genes that match
each GO term. The pie chart sections represent GO terms biological
processes, cellular components and molecular functions. The GO
analysis gives a broad overview of the biological significance of the
differentially regulated genes. Figure (A) represents differentially
regulated genes by PAK1 whereas (B) represents differentially expressed
genes regulated by Pak1 that were responsive to IR.
doi:10.1371/journal.pone.0066585.g003

PLOS ONE | www.plosone.org

8

August 2013 | Volume 8 | Issue 8 | e66585

PAK1 Genome-Wide Targets during DNA Damage

Figure 5. Gene Ontology Tree for Biological Process. A Hierarchical representation of GO terms for biological processes. Panel (A) Represents
lower level classifications of biological processes by PAK1 regulated genes which includes developmental processes, cellular adhesion, and regulation
of cell motility and cell proliferation. Panel (B) Shows lower level classifications of biological processes for PAK1 regulated DNA damage responsive
genes. These genes are mostly involved in cell cycle arrest, cell death, response to stress and apoptosis. All the categories are statistically significant
with P- value,0.01.
doi:10.1371/journal.pone.0066585.g005

were any distinct transcription factors governing the characteristic
features of Pak1 targets in IR and non-IR scenarios.

were also implicated in functions that were explored using GO
analysis. For example, transferases were an important component
of molecular functions like DNA binding and catalytic activity,
many transporters involved in enzyme activity and signaling
molecules, were implicated in biological processes like cellular
regulation. We can see that transcription factors are the major
players of genomic regulation through Pak1 in both IR and nonIR scenarios. Transcriptional targets of Pak1 have been extensively studied with respect to cytoskeleton remodeling like the
estrogen receptor a (ERa), Forkhead transcription factor (Fkhr),
SHARP and EMT transitions [36] but here for the first time we
explore the transcriptional targets of Pak1 in many different
cellular processes and in response to DNA damage which can
either be directly or indirectly influenced by PAK1. To understand
the transcriptional regulation of Pak1 we further analyzed if there

PLOS ONE | www.plosone.org

Transcription Factors analysis by IPA
Since we found that transcription factors were over represented
in the gene families we performed the transcription factor analysis
from IPA (release Winter 2012) to find the top transcription factors
regulating majority of targets in both IR and non-IR scenarios.
Distinct set of transcription factors were up- and down- regulated
in the two scenarios. The non-IR scenario consisted of transcription factors as CEBPA, VDR, SPDEF, MLL2, and NR3C1,
whereas the IR scenario comprised of TP53, ESR2, NFkB
(complex), TP63, and JUN. CEBPA, CCAAT/enhancer-binding
protein alpha transcription factor is deregulated in acute myeloid
leukemia which results in differentiation and increased prolifera-
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Figure 6. Top five KEGG pathways. DAVID tool was used to analyze differentially regulated genes to identify top pathways that were influenced
by these subset of genes. Panel (A) shows the graph representing the top pathways for genes being regulated by PAK1 whereas panel (B) represents
pathways for genes regulated by PAK1 in response to DNA damage. The analysis utilized p value,0.1 and Benzamini Hochberg, Bonferroni and FDR
corrections were applied for minimize the number of false positives.
doi:10.1371/journal.pone.0066585.g006
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Table 5. The top KEGG pathways by DAVID tool in non-IR
scenario.

Term

Count

% of
genes

22

3.09

3.41E-04

Pathways in cancer

23

3.23

0.00523118

Purine metabolism

13

1.82

0.0158467

Focal adhesion

15

2.10

0.01796474

Endocytosis

15

2.10

0.02099121

Axon guidance

11

1.54

0.02672229

Toll-like receptor signaling pathway

9

1.26

0.03380387

Metabolism of xenobiotics by
cytochrome P450

7

0.98

0.03836115

13

1.82

Term

Count

% of genes

P-Value

p53 signaling pathway

8

4.10

1.31E-05

Pathways in cancer

10

5.12

0.012073

Bladder cancer

4

2.05

0.012626

Notch signaling pathway

4

2.05

0.020181

Glioma

4

2.05

0.038248

Propanoate metabolism

3

1.53

0.047369

P-Value

Cytokine-cytokine receptor interaction

Chemokine signaling pathway

Table 6. The top KEGG pathways by DAVID tool in IR
scenario.

0.04350035

p53 signaling pathway

7

0.98

0.04613989

Cytosolic DNA-sensing pathway

6

0.84

0.05656196

Drug metabolism

7

0.98

0.06445811

Bladder cancer

5

0.70

0.0737393

NOD-like receptor signaling pathway

6

0.84

0.08537709

Melanoma

4

2.05

0.049558

Chronic myeloid leukemia

4

2.05

0.058529

Cell cycle

5

2.56

0.061736

Cytokine-cytokine receptor
interaction

7

3.58

0.064104

ErbB signaling pathway

4

2.05

0.080734
0.080734

Apoptosis

4

2.05

Prostate cancer

4

2.05

0.087345

MAPK signaling pathway

7

3.58

0.087658

doi:10.1371/journal.pone.0066585.t006
doi:10.1371/journal.pone.0066585.t005

to be involved in cell death due to ionizing radiation. Gtse1 and
Mdm2 were important targets in P53 signaling which was the top
pathway in the IR scenario. The protein encoded by Gtse1 is only
expressed in the S and G2 phases of the cell cycle. During this
phase it colocalizes with cytoplasmic tubulin and microtubules. In
response to DNA damage, the protein aggregates in the nucleus
and binds P53, thus pushing it out of the nucleus and suppressing
its ability to induce apoptosis. [40]. This protein shares many
functions as PAK1 like the association with cytoplasm dynamics
and its localization in the nucleus. Such correlations bring out
interesting association which one might want to explore. From the
non-IR dataset, we chose to validate the alteration of Thymosin
beta 4, X-linked (Tmsb4x) and regulator of G-protein signaling 4
(Rgs4) that were up-regulated in the Pak1-KO MEFs as compared
with WT MEFs revealed by microarray analysis. Tmsb4x gene
encodes an actin sequestering protein which binds to and
sequesters actin monomers (G actin) and therefore plays a role
in regulation of actin polymerization [41,42]. The protein is also
involved in cell proliferation, migration, and differentiation.
Recent study revealed that Tmsb4x is likely to be ERb target gene
identified by microarray analysis of altered gene expression in
ERb-overexpressing HEK293 cells [43], and induced under
hypoxic conditions in murine melanoma B16 (F10) cells [44].
Overexpression of Tmsb4x is associated with increased invasion of
SW480 colon carcinoma cells and the distant metastasis of human
colorectal carcinoma [45]. Regulator of G protein signaling (RGS)
proteins are GTPase-activating proteins for heterotrimeric G
proteins. RGS4, has been to increase cell adhesion and migration
in human glioma cells [46] and promote cell survival of thyroid
cancer cell [47]. By contrast, the tumor suppressor function of
RGS4 was also proposed. Also RGS4, is associated with cancer
cell motility and shown to selectively inhibit Rac-activated
lamellipodia formation in breast cancer cells [48]. Pak1 is also
known to induce lamellipodia, filopodia and membrane-ruffle
formation [1,3]. More importantly, both proteins have been
shown to play a critical role in breast cancer manipulating cell
motility but no connection between them is reported so far.
Further studies are needed to uncover such relationships between
molecules which might lead to novel therapeutic interventions. Till

tion of cells. The CEBPA is thought to be deregulated post
translationally, by RNA interference or through transcriptional
silencing [37]. CEBPA is predicted to regulate the expression of
these upregulated or down regulated genes directly or indirectly.
Few targets of this transcription factor are BTG2, CSF1R,
DYNLT3, EPHX1, MT2A, and VDR. We observe that VDR
being a transcription factor is one of the targets of CEBPA. This
kind of analysis provides insights to common targets of the
transcription factors as well as the regulatory interplay among the
transcription factors that might be occurring due to loss of PAK1.
In the IR scenario P53 is one of the major transcriptional
regulators. A network of P53 and its targets predicted from our
gene list is presented at Figure 8. CDKN1A and MDM2 known to
bind P53 [38] [39], the other genes that are predicted to be
regulated by P53 are DGKA, ADRB2 but have not been explored
till date. Such analysis and visualization can help us infer that if
there is a genomic regulation between PAK1 and TP53 then all
these associated molecules will be affected by this interplay and
will have an effect on the downstream signaling pathways. The top
5 transcriptional regulators for each scenario are present in
Tables 7 and 8 and the entire list is available in Tables S9 and S10.

Validation
To validate the results obtained from microarray analysis we
chose several differentially expressed genes that are regulated by
Pak1. The selection of the genes for validation was based on the
interest of laboratory, role of the gene in top functions and
pathways and significant fold change regulation. They include
Ptgs2 (3.3 fold upregualted), Tmsb4x (3.2 fold upregulated), Wnt10b
(2.8 fold down regulated), F3 (2.5 fold down regualted), Rgs4
(upregualted by 3.4 fold change), Nipsnap1 (3 fold down regulated),
and Car12 (2.9 down regulated) from the non–IR scenario.
(Figure 9) and Ddit4 (14 fold upregulation), Eda2r (5 fold change
upregualted), Gtse1 (3.5 fold upregualted), Mdm2 (6 fold upregualted), Phlda3 (3.8 fold upregulated), Pmaip1 (9 fold upregualted),
from the IR scenario (Figure 10) DDdit4, Phlda3, Pmaip1 and Eda2r
were all highly upregulated due to loss of Pak1 and were predicted
PLOS ONE | www.plosone.org

11

August 2013 | Volume 8 | Issue 8 | e66585

PAK1 Genome-Wide Targets during DNA Damage

Figure 7. Gene family classification from PANTHER. This figure represents various gene families that are over or under represented for both IR
and non-IR scenarios. The over and underrepresented families are computed by comparing the gene families in our list to a reference genome which
in this case was Mus Musculus. Binomial distribution is applied to obtain p-values and p values,0.05 were considered. Percentage of genes for each
gene family that were differentially represented are shown in the figure. Transcription factors are the most over-represented gene family in both IR
and non-IR conditions.
doi:10.1371/journal.pone.0066585.g007

expressed in wild-type and Pak1-knockout cells and 199 that were
regulated by Pak1 and were responsive to ionizing radiation. Gene
ontology, KEGG pathway and IPA network analyses revealed that
these differentially expressed genes are involved in specific cellular
processes, signaling pathways, and gene networks. The genes that
were regulated by Pak1 in IR scenario were specifically involved in
cell cycle arrest and apoptotic events in response to DNA damage.
This is important because the inability to control cell cycle
progression is the root cause of cancer development. To target one
of the most elementary steps is very important in order to cure a

now no studies have reported the regulation of these genes by
Pak1. Based on these observations, we hypothesize that these
targets are novel and their regulation by Pak1 could be further
explored.

Conclusions
In summary, in this study we provide the first genome-wide
analysis of Pak1 target genes upon exposure to a DNA damaging
agent. A total of 732 probe sets were identified to be differentially
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Figure 8. Network of P53 and its targets regulated by PAK1 using STRING database. In the figure transcription factor P53 and its targets
are represented. Brown lines represent expression; blue lines represent binding, green lines represent activation of the target molecules whereas pink
lines represent post translational modifications mediated by P53. MDM2, Ddit4, PHLDA3, CDKN1A are few of the P53 targets that are also influenced
by Pak1 knock out.
doi:10.1371/journal.pone.0066585.g008

Table 7. Top transcription factors by Ingenuity Pathway Analysis in non-IR scenario.

Transcription
Regulator

p-value

Target molecules in dataset

CEBPA

2.11E-06

BTG2,CSF1R,DYNLT3,EPHX1,IFI27,MT2A,NFIL3,PFN2,PLOD2,RGS2 ,SERPINF1,SPINT2,SPP1 ,THBD,TUBB2A,VDR

VDR

5.39E-06

CDKN1A,IGFBP3,PLCG1,THBD,UCP2

SPDEF

5.78E-06

BIRC3,CD34,CDH11,COL4A2,COL4A6,COL5A2,CTGF,ITGA6,PLAU,SMAD1,TGFB1

MLL2

1.21E-05

CRIP1,CRIP2,ENO3,FHL1,GPR56,GPR64,NPR3

NR3C1

2.58E-05

AKTIP,BIRC3,CASP4,CDKN1A,CORO2A,CTNNBL1,CUL4A,GEM,IFIH1,IL6,ING1,NLRP10,PAK1,PAX3,PHF17,PLAGL1,POGK,
PTGS2,RGS2,SDPR,SH3KBP1,SMAD1,SOX4,SPP1 ,STAT6,THBD,TNFAIP2,TNFRSF10A,TNFRSF11B,TNFRSF21,TRAF3IP2

doi:10.1371/journal.pone.0066585.t007
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Table 8. Top transcription factors by Ingenuity Pathway Analysis in IR scenario.

Transcription Regulator

p-value

Target molecules in dataset

TP53

5.78E-05

ADRB2,APAF1,BTG2,CDKN1A,DDIT4,DGKA,FAS,GDF15,MDM2,MYBL1,MYC,NOTCH1,PHLDA3,TAP1,TNFRSF10A

ESR2

9.03E-05

CDKN1A,CXCL12,EREG,MYC

NFkB (complex)

1.10E-04

CCNB2,CDKN1A,CXCL10,CXCL12,FAS,GDF15,MDM2,MYC,TAP1

TP63

1.19E-04

APAF1,CDKN1A,FAS,MDM2,TNFRSF10A

JUN

1.43E-04

CDKN1A,CXCL10,DUSP1,EREG,JUN,MYC

doi:10.1371/journal.pone.0066585.t008

Invitrogen (Carlsbad, CA). Cells were irradiated with a Nasatron
137Cs irradiator (U.S. Nuclear, Burbank, CA) at a dose rate of
3.04 Gy/min at room temperature. Control cultures were
identically processed but not irradiated. Total RNA was isolated
using TRIzol reagent (Invitrogen, Carlsbad, CA) following the
protocol provided by the manufacturers, and then purified using
RNeasy Mini Kit (Qiagen, Valencia, CA) and tested for integrity
on RNA 6000 NanoChips using an Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA).

disease. Genes involved in cellular growth proliferation, DNA
replication, recombination and repair formed the most significant
cluster in our dataset which leads us to the hypothesis that most of
the genes affected by Pak1 knock out are involved in repairing the
DNA damaged by ionizing radiation which lead to better cell
survival. This data set opens new avenues of understanding the
genomic regulation of these genes by Pak1 which can provide an
insight into genomic instability of the cancer genome. The data
analysis also revealed a genomic regulation between Pak1 and
major transcriptional regulators such as P53, NF-kB, JUN that
control a big cluster of targets. Genome wide microarray analysis
has been performed for the first time to indentify the role of Pak1
and its regulatory targets during genotoxic insults such as DNA
damage. In contrast, in the non-IR condition where functions of
Pak1 in areas such as developmental process and metabolic
process functions still remain very poorly defined, our data
provides a rich source for future investigation. The data analysis
also reveals class of signaling molecules, histones and enzymes
being significantly affected by the loss of Pak1. The association of
Pak1 with histones and transcription factors provides new targets
that can be tested for its association with nucleus and the
chromatin. Accumulating evidence has pointed out that there are
several potential mechanisms responsible for PAK1 regulation of
gene transcription. First, nuclear PAK1 associates with chromatin
and regulates histone modifications such as phosphorylation of
histone H3 at serine 10, which in turn directs gene transcription
[13,14]; second, PAK1 may interact with and phosphorylate
transcription factors, transcription coregulators, or chromatin
remodeling factors, thus regulating the bindings of the transcription machinery to nucleosomal DNA and consequently, gene
transcription. A case in point is that PAK1 interacts with and
phosphorylates transcriptional corepressor SHARP and enhances
SHARP-mediated repression in Notch signaling [49]. Similarly
the families of signaling molecules and enzymes can be tested for
various developmental and metabolic processes. The presented
data on one hand re-emphasizes the overall known function of
Pak1 and the identification of new targets also definitely points to
the unexplored biological functions of Pak1. Collectively, these
identified candidate targets of Pak1 and their associated functional
analysis may provide new avenues to further explore the possibility
of developing these targets as biomarkers as well as identifying
novel functions and regulatory mechanisms of Pak1.

Microarray gene expression assays and data analysis has been
performed as described previously [51]. In brief, rRNA reduction
of the purified total RNA samples was performed using the
RiboMinusTM Transcriptome Isolation Kit (Invitrogen, Carlsbad,
CA). The rRNA-reduced samples were then amplified and labeled
using the GeneChipH Whole Transcript cDNA Synthesis/Amplification Kit and GeneChip Whole Transcript Terminal Labeling
Kit (Affymetrix, Santa Clara, CA). Labeled single-stranded DNA
samples were then prepared in a volume of 220 ml of hybridization
mixture using the Hybridization Module of the GeneChip
Hybridization, Wash and Stain Kit from Affymetrix. For each
sample, 200 ml of hybridization mixture was hybridized on a
GeneChip Mouse Exon 1.0 ST Array (Affymetrix, Santa Clara,
CA), which contains more than 266,000 probe sets, at 45uC with
60 rpm rotation in an Affymetrix Hybridization Oven 640 for
17 h. Following hybridization the arrays were scanned on an
Affymetrix GeneChip Scanner 3000 7G, after the wash and
staining on an Affymetrix Fluidics Station 450.
For microarray data analysis, results were saved as a .CEL file
using the Command Console for each of the arrays. Data were
processed in GeneSpring GX by statistical analysis using unpaired t
test with p value computations done asymptotically and multiple
corrections as Benjamin Hochberg, FDR were applied with a p value
cut-off of 0.05. Heat map analysis of the identified genes for individual
arrays was performed using MultiExperiment Viewer version 4.4.
Gene ontology (GO) analysis was performed using GeneSpring GX
10.0.2. The data discussed in this publication has been deposited in
NCBI’s Gene Expression Omnibus [52] and are accessible through
GEO Series accession number GSE47503 (http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc = GSE47503).

Materials and Methods

Pathway and functional analysis

Microarray gene expression assays and data analysis

Gene Ontology analysis from GeneSpring GX 10.0.2. was used
to identify GO terms , molecular functions and biological processes
at a p value cut off set to 0.1. The datasets of differentially expressed
genes in the WT and Pak1-KO as well as PAK1 regulated IR
responsive genes, were analyzed using Ingenuity Pathway Analysis
to discover relationships between the genes. DAVID 6.7 was used to
perform the pathway analysis using the KEGG pathways. The

Cell culture, Ionizing radiation treatment and RNA
isolation
Pak1 WT and Pak1 KO MEFs [50] were maintained in
DMEM/F-12 medium supplemented with 10% fetal bovine
serum and 16 antibiotic-antimycotic solution in a humidified
5% CO2 at 37uC. All cell culture reagents were purchased from
PLOS ONE | www.plosone.org
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Figure 9. Microarray validation of targets regulated by PAK1. The RT-qPCR was performed in duplicates for each of the triplicate WT and
Pak1-KO RNA sample from MEFs. The relative mRNA expression levels is represented in the figure and the p-values were computed. The orange bars
show the expression data from Microarray and the green bars represent expression levels obtained by q-PCR. The Ct values of the genes were
normalized with the Ct values of 18S.
doi:10.1371/journal.pone.0066585.g009

isolated by using TRIzol reagent (Invitrogen), and 2 mg of total RNA
was reverse-transcribed using the SuperScript III First-strand
synthesis system for reverse transcriptase-PCR (Invitrogen). Quantitative PCR (QPCR) was done by using iQTM SYBR Green Supermix
(Bio-Rad Laboratories, Hercules, CA) on an iCycler iQ real-time
PCR detection system (Bio-Rad Laboratories, Hercules, CA). The

Fisher’s exact test was used to identify significant functions and
pathways represented within the respective datasets.

RT-qPCR and Western blot analysis
RT-qPCR and Western blot analysis were performed following the
protocol described previously [53,54]. In brief, total RNA was
PLOS ONE | www.plosone.org
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Figure 10. Microarray validation of targets regulated by PAK1 and responsive to IR. The RT-qPCR was performed in duplicates for each of
the triplicate WTIR and KOIR RNA sample. The WT and Pak1-KO RNA samples from MEFs were subjected to ionizing radiation. The relative mRNA
expression is represented in the figure and the p-values were computed. The orange bars show the expression data from Microarray whereas the
green bars represent expression levels obtained by q-PCR. The Ct values of the genes were normalized with the Ct values of 18S.
doi:10.1371/journal.pone.0066585.g010

real time PCR Ct values for specific genes were normalized to
housekeeping control 18S. Primer sequences are available on request.
For Western blot analysis of Pak1 expression in the WT and
Pak1-KO MEFs, protein extracts were prepared by lysing the cells
in the RIPA lysis buffer containing 50 mM Tris-HCl (pH 7.4), 1%
Nonidet P-40, 150 mM NaCl, 1 mM ethylenediaminetetraacetic
acid, 0.25% sodium deoxycholate, 16protease inhibitor mixture
(Roche, Indianapolis, IN), and 16phosphatase inhibitor mixture I

PLOS ONE | www.plosone.org

and II (Sigma, St. Louis, MO), and protein concentrations were
determined by using Bio-Rad DC Protein Assay reagents (Bio-Rad
Laboratories, Hercules, CA). Cell lystaes were then resolved by
sodium docecyl sulfate-polyacrylamide gel electrophoresis, transferred to nitrocellulose membranes, and incubated with respective
antibodies. Rabbit polyclonal anti-Pak1, mouse monoclonal antivinculin primary antibodies, and horseradish peroxidase-coupled
secondary antibodies were obtained from Bethyl Laboratories
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The top networks by IPA in both non-IR and
IR scenarios.
(XLSX)

(Montgomery, TX), Sigma-Aldrich (St. Louis, MO), and Amersham Biosciences (Piscataway, NJ), respectively.

Table S7
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